Prab: CSV import

2025-03-18T02:45:50Z

CSV import

← Older revision		Revision as of 02:45, 18 March 2025
Line 27:		Line 27:
	{{stub}}		{{stub}}
	{{No image}}		{{No image}}
			__NOINDEX__

Prab: CSV import

2025-02-10T23:49:08Z

CSV import

← Older revision		Revision as of 23:49, 10 February 2025
Line 26:		Line 26:

	{{stub}}		{{stub}}
			{{No image}}

Prab: CSV import

2024-02-24T07:33:09Z

CSV import

New page

'''Tissue selectivity''' refers to the ability of a drug or other therapeutic agent to affect specific tissues more than others. This property is often exploited in drug design to increase the effectiveness of a drug while minimizing side effects.

== Overview ==

Tissue selectivity is a key factor in the development of many drugs. It allows for the targeted delivery of therapeutic agents to specific tissues, thereby increasing the effectiveness of the drug and reducing the risk of side effects. This is particularly important in the treatment of diseases such as cancer, where the aim is to destroy cancerous cells without harming healthy ones.

== Mechanism of Action ==

The mechanism of action of tissue selective drugs often involves the interaction with specific receptors or enzymes that are predominantly expressed in the target tissue. For example, [[Tamoxifen]], a drug used in the treatment of [[breast cancer]], is selective for estrogen receptors that are overexpressed in breast cancer cells.

== Advantages and Disadvantages ==

The main advantage of tissue selectivity is the potential to increase the effectiveness of a drug while reducing side effects. However, there are also potential disadvantages. For example, if a drug is too selective, it may not affect all the cells in a tumor, leading to incomplete treatment. Furthermore, the development of tissue selective drugs can be more complex and costly than the development of non-selective drugs.

== Examples ==

There are many examples of tissue selective drugs. These include [[Tamoxifen]] for breast cancer, [[Finasteride]] for benign prostatic hyperplasia, and [[Salmeterol]] for asthma.

== Future Directions ==

The development of more tissue selective drugs is a key area of research in pharmacology. Advances in our understanding of the molecular basis of disease, coupled with advances in drug delivery technologies, are likely to lead to the development of more effective and safer drugs in the future.

[[Category:Pharmacology]]
[[Category:Drug design]]
[[Category:Medical terminology]]

{{stub}}

Tissue selectivity - Revision history

Prab: CSV import

Prab: CSV import

Prab: CSV import